✦ LIBER ✦

Reduction of Immune System Activation in HIV-1-Infected Patients Undergoing Highly Active Antiretroviral Therapy

✍ Scribed by J. M. Franco; A. Rubio; C. Rey; M. Leal; J. Macías; J. A. Pineda; B. Sánchez; A. Sánchez-Quijano; A. Nuñez-Roldán; E. Lissen

Publisher: Springer
Year: 1999
Tongue: English
Weight: 67 KB
Volume: 18
Category: Article
ISSN: 0934-9723
DOI: 10.1007/s100960050388

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immune reconstitution inflammatory syndr

Immune reconstitution inflammatory syndrome after initiating highly active antiretroviral therapy in HIV-infected children

✍ Tracy Kilborn; Marco Zampoli 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 300 KB

Effect of Highly Active Antiretroviral T

Effect of Highly Active Antiretroviral Therapy on Hospitalization Characteristics of HIV-Infected Patients

✍ R. Nuesch; N. Geigy; E. Schaedler; M. Battegay 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 128 KB

Skin-Related Quality of Life in HIV-infe

✍ Paradi Mirmirani; Toby A. Maurer; Timothy G. Berger; Laura P. Sands; Mary-Margar 📂 Article 📅 2002 🏛 Springer-Verlag 🌐 English ⚖ 191 KB

Impact of Highly Active Antiretroviral T

Impact of Highly Active Antiretroviral Therapy on Fever of Unknown Origin in HIV-Infected Patients

✍ F. Lozano; J. Torre-Cisneros; J. Santos; E. León; A. Domínguez; M. Montesdeoca; 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 19 KB

Effect of Pneumococcal Vaccine on Plasma

Effect of Pneumococcal Vaccine on Plasma HIV-1 RNA of Stable Patients Undergoing Effective Highly Active Antiretroviral Therapy

✍ E. Negredo; P. Domingo; M. A. Sambeat; N. Rabella; G. Vázquez 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 44 KB

Soluble urokinase plasminogen activator

Soluble urokinase plasminogen activator receptor is a marker of dysmetabolism in HIV-infected patients receiving highly active antiretroviral therapy

✍ Ove Andersen; Jesper Eugen-Olsen; Kristian Kofoed; Johan Iversen; Steen B. Hauga 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB

## Abstract Circulating soluble urokinase plasminogen activator receptor (suPAR) reflects the immune and pro‐inflammatory status of the HIV‐infected patient. Highly active antiretroviral therapy (HAART) suppresses suPAR. Independent of the immune response to HAART, suPAR remains elevated in some HI